logo
Terri Schiavo's Legacy: When to Ethically Stop Life Support

Terri Schiavo's Legacy: When to Ethically Stop Life Support

Medscape30-07-2025
This transcript has been edited for clarity.
Hi. I'm Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City.
Twenty years ago this month, from the time I'm talking with you, in March 2005, a young woman named Terri Schiavo was allowed to die. It was one of the most controversial, and probably the most important, end-of-life-care cases ever to unfold in the United States.
Terri was left permanently unconscious after a heart attack. Her husband [Michael Schiavo], after efforts were made to see if they could revive her and after efforts were made to see if she really was permanently unconscious, basically said she would not want to be in this state.
She was kept alive by artificial nutrition, artificial fluids, and he said she just wouldn't want to be hereunable to think, sense, or feel, implying, "I know her, I have decision-making authority, and I want her feeding tubes and her artificial fluids disconnected. I want her to be allowed to die. That's what she would want." He wasn't saying that's what he would want. He said that's what she would want, acting as her, if you will, guardian or person making a substituted judgment.
Terri's parents and her brother did not agree. They felt that Terri might recover. They also argued that they weren't totally convinced she was completely unable to communicate, think, feel, or hear. They made tapes when they went to visit her that suggested that she wasn't totally unconscious and was somewhat responsive.
They went to court in the state of Florida where Terri was after her heart attack in a long-term care facility and engaged in a legal battle with Michael, the husband, to keep her alive. That fight took over 8 years, I think. It went up and down the Florida court system as to who could make the decision on whether artificial nutrition and fluids could be stopped.
The fight reached 14 Florida courts, up and down their appellate system, then five federal courts, then intervention from the US Congress on the side, I should add, of Terri's parents and siblings. There were people arguing from the floor of Congress, including Congressman David Weldon and Senator Bill Frist [both of whom are physicians], that they didn't think she was in a permanent vegetative state.This was very controversial because they made that diagnosis based on videos, without seeing her.
Ultimately, the Supreme Court was approached. They said they were not going to hear the case, but the last court decision gave authority to the husband. On March 31, 2005, Terri's artificial life support was discontinued and she died.
That case has reverberated throughout American healthcare ever since. It's not just a story of how we got to where we are in terms of having the right to stop care that a person doesn't want. This set the stage for stopping care that some people think is not medical care — food and water — but others argue quite vociferously that it's technology coming through a tube made out of special solutions,not eating pudding off a spoon.
One issue that seems to have been resolved by the Schiavo case is that artificial feeding, artificial life support, and artificial fluids are medical technologies and can be stopped. At the same time, we have had many arguments since about how you adequately diagnose permanent vegetative state.
Some scientists today are arguing that even with what we think is permanent vegetative state, there still may be some consciousness there. I don't believe that was true at all for Terri because on autopsy, her brain had shrunk to the size of a walnut. Her optic nerves had disconnected from her brain. She would not have been able to sense, feel, observe, or respond to any stimuli.
Do we have to make a more precise diagnosis of permanent vegetative state before we get into arguments about what to do next? I do believe also that it's important, if you are dealing with someone who's terminally ill or has a serious illness, to get the discussion going early about who's in charge.
We still have fights between husbands, families, sisters, and cousins coming in about who has veto power or decision-making power. The earlier we can establish who it is that the patient wants to speak for them if they can't, the better.
Reenacting that war that we saw in the courts and Congress over Terriis a lesson that early communication, although it's hard to do, can really save terrible and disturbing emotional battles — not only for the family, but also for the nurses, doctors, and everybody who's involved in treating someone when one of these fights breaks out about stopping food and water, shutting off the ventilator, or stopping dialysis or antibiotics.
Terri has quite a legacy. She left us with the understanding that it is possible legally and ethically to end life support, that someone else can make that decision, and that a [spouse] has more standing than the rest of the family. Given all that, it's still important to engage in early, explicit discussion about who ought to be in charge if the patient can't be.
I'm Art Caplan, at the Division of Medical Ethics at NYU Grossman School of Medicine. Thanks for watching.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Psoriasiform Dermatitis Risk in Children on TNFi Reviewed
Psoriasiform Dermatitis Risk in Children on TNFi Reviewed

Medscape

time32 minutes ago

  • Medscape

Psoriasiform Dermatitis Risk in Children on TNFi Reviewed

TOPLINE: Older age at TNF alpha inhibitors initiation, a diagnosis of juvenile idiopathic arthritis (JIA), and concomitant immunomodulator use were associated with delayed onset of paradoxical psoriasiform dermatitis (PD) in children treated with TNFi, in a retrospective chart review. METHODOLOGY: Researchers conducted a retrospective chart review of 3418 patients receiving TNFi therapy for various conditions (including Crohn's disease, JIA, and ulcerative colitis) at Cincinnati Children's Hospital Medical Center, Cincinnati, from January 2018 to January 2023. Overall, 70 patients (2%) developed PD skin eruptions (52.9% women; 91.4% White; 5.7% Black; median age at TNFi initiation, 11.7 years; median age at PD onset, 13.6 years); 21.4% of patients were given concomitant immunomodulators; 94% of patients had PD at multiple sites. The median time from starting a TNFi to the onset of PD was 16.9 months. Treatments for PD included topical steroids (85.7%), systemic medications (15.4%), and nonsteroid topicals including tacrolimus, pimecrolimus, and calcipotriene (24.3%). PD outcomes and factors associated with its severity were evaluated. TAKEAWAY: PD rashes resolved in 32 patients (45.7%); the median time to resolution was 15.5 months. Most (71.4%) of those with PD had Crohn's disease, and infliximab (52.7%) and adalimumab (44.6%) were the most frequently used TNFi. The initial TNFi was discontinued in 40 patients (57.1%) because of PD in 23 (57.5) of those patients. Of these 40 patients, 12 (30%) switched to another TNFi with a 33% recurrence rate, while 25 (62.5%) switched to a different medication class with PD persisting in 36%. Girls were more likely to receive high-potency topical steroids, possibly indicating a difference in prescribing practices or worse disease. Onset of PD occurred later in patients with JIA (coefficient estimate [CE], 22.6 months; P = .02), those on concomitant immunomodulators (CE, 11.0; P = .04), or those who were older when the TNFi was started (CE, 2.4; P < .01). IN PRACTICE: 'Our study found that the diagnosis of JIA, older age at TNFi initiation, and concomitant immunomodulation are potential predictors of later PD onset,' the authors of the study concluded. 'Female sex may influence PD severity,' they added, 'but conflicting results and the retrospective design of this study call for additional research to better understand the factors contributing to PD severity in pediatrics.' SOURCE: This study was led by Muayad M. Shahin, University of Cincinnati College of Medicine, Cincinnati, and was published online on July 31, 2025, in Pediatric Dermatology. LIMITATIONS: The retrospective study design limited the availability of detailed morphologic descriptions. Additionally, multiple definitions of severe PD restricted analysis of risk factors across different outcome measures. DISCLOSURES: This research was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Core Center and the University of Cincinnati Office of Research medical student summer research award, funded by the Stella and Carey Wamsley Charitable Trust. One author disclosed serving as a consultant for LEO Pharma. The other authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Rural Parents See More Care Gaps and Delays After Pregnancy
Rural Parents See More Care Gaps and Delays After Pregnancy

Medscape

time32 minutes ago

  • Medscape

Rural Parents See More Care Gaps and Delays After Pregnancy

TOPLINE: Parents in the year following birth residing in rural areas experienced more healthcare barriers, including reduced access to obstetric care and increased emergency department visits, than their urban counterparts. While infant care was similar between rural and urban areas, postpartum parents reported delays in medical care compared with their infants in both settings. METHODOLOGY: Researchers conducted a cross-sectional analysis using data from the National Health Interview Survey to examine rural-urban differences in healthcare access in postpartum parents and infants. They included nonpregnant women aged 18-49 years who had infants aged 1 year or younger. A total of 2019 postpartum parents (mean age, 27.1 years) and 2191 infants residing in rural areas, and 12,112 postpartum parents (mean age, 29.2 years) and 13,088 infants residing in urban areas were included in the study. Self-rated health was assessed on a five-point scale ranging from excellent to poor for both postpartum parents and infants. Healthcare utilization was evaluated based on the location where the care was received, the number of office or emergency department visits in the prior year, visits to specific clinicians, and the number of hospitalizations. Barriers to care were categorized into insurance coverage issues (such as gaps in coverage, losing coverage after pregnancy, or changes in care location) and reasons for delayed medical care. TAKEAWAY: Parents residing in rural areas were less likely to see an obstetrician-gynecologist (P = .002), visited the emergency department more frequently (P = .030), and had more hospitalizations (P = .041) than those residing in urban areas. Parents residing in rural areas experienced more disruptions in medical care, gaps in insurance coverage, and loss of Medicaid coverage after pregnancy than their urban counterparts. Delays in medical care were also more prevalent among parents residing in rural vs urban areas (20.3% vs 15.8%; P = .009); this pattern was not observed among infants. Among both rural and urban parent-infant dyads, adults were more likely to experience uninsurance and delayed medical care than their infants. Cost was a more common reason for delayed care among postpartum parents than among infants in the same household, regardless of where they lived. IN PRACTICE: 'Investments in rural health care infrastructure may support rural families,' the authors wrote. 'Integrating and incentivizing care for postpartum parents alongside their infants may address differential use and access to care in this critical period.' SOURCE: The study was led by Sara C. Handley, MD, MSCE, of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. It was published online on August 3, 2025, in The Journal of Rural Health. LIMITATIONS: The analysis did not include specific weighting to represent the US population of parent-infant dyads. The cross-sectional design did not specify the age of the infant, which could have affected the reported number of visits and limited comments on completeness of the care. DISCLOSURES: The study received support through grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the University of Minnesota Foundation Rural Health Research Center Fund, and the Federal Office of Rural Health Policy. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Importance of colorectal cancer screenings
Importance of colorectal cancer screenings

Yahoo

timean hour ago

  • Yahoo

Importance of colorectal cancer screenings

NEW HAVEN, Conn. (WTNH) — Younger adults are facing a silent threat: colorectal cancer cases are on the rise, and experts say it's hitting harder and earlier than ever before. Madhavi Bhoomagoud, a Hartford HealthCare Digestive Health Institute gastroenterologist with Midstate Medical Center, spoke with News 8's Keith Kountz about the most common warning signs and symptoms of colorectal cancer that should never be ignored. She also explains what is behind the rise in colorectal cancer cases among younger adults, even those under age 45 who aren't eligible for screening yet. Watch the video above and visit or call 860-901-7008 for more information. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store